The nearly $1 billion won by VirnetX in patent trials against Apple Inc. exists under a cloud since the Patent Trial and Appeal Board has found the patents invalid. With appeals pending from the board's decisions and one of the trials, here's a look at VirnetX's arguments that the patents shouldn't have been reviewed, and Apple's efforts to flip the verdict.
European generic drug makers have launched a campaign to amend European Union plans to offer six months of extended marketing exclusivity for drugs that undergo pediatric testing.
The U.S. House of Representatives has approved a bill that would make it easier for owners of famous brands to sue for trademark dilution.
The U.S. Court of Appeals for the Federal Circuit has overturned a California federal court’s decision to invalidate a satellite-control technology patent belonging to Loral Space & Communications Ltd. in a patent suit against Lockheed Martin Corp.
Industry representatives praised plans for sweeping reforms of the U.S. patent system at a hearing held Wednesday in the U.S. House of Representatives.
In an ominous development for European futures traders, the European Patent Office has awarded a broad patent to a software maker that has vowed to take on the entire industry in an effort to obtain licensing agreements for its trading platform.
Buchanan Ingersoll LLP has hired two seasoned telecommunications and intellectual property litigators from Fish & Richardson in an effort to rebuild its IP practice in San Diego after a number of defections to Duane Morris.
In a case with broad implications for the pharmaceutical industry, the U.S. Supreme Court appeared skeptical Wednesday of an appeal court’s narrow interpretation of a statute that shields drug companies from patent liability in their research and development.
Jones Day has hired the former chief legal adviser of Sony Music Entertainment in Germany for the firm’s Frankfurt office.
In a move that gives Howrey LLP responsibility for managing the Toyota marquee and other famous brands, the firm’s Washington, DC office has hired two seasoned trademark partners from Shaw Pittman.
A new copyright bill is headed for the President’s signature after both the U.S. Senate and the House of Representatives passed the measure, which would crack down on piracy and permit technologies that allow users to skip “objectionable” content in movies.
A company known for the aggressive way in which it enforces its portfolio of high-tech patents has sued Intel Corp. and Texas Instruments Corp. over a chip design patent.
Duane Morris LLP has hired Bradford J. Duft to its San Diego office, the fourth attorney the firm has poached from Buchanan Ingersoll PC.
Chicago-based intellectual property specialist Marshall, Gerstein & Borun LLP has elected Jeffrey Sharp as managing partner for a second three-year term.
A federal judge has dismissed Tercica, Inc.’s and Genentech, Inc.’s patent infringement lawsuit against rival Insmed Inc. over its SomatoKine growth hormone treatment.
Howrey LLP has acquired Cabinet Cousté & Cousté, one of France’s leading intellectual property firm, in a deal that will give the law firm an IP arm in Paris.
Generic drug makers Dr. Reddy's Laboratories and Ivax have vowed to appeal last week's ruling by an Indiana federal court that upheld Eli Lilly's patent on the blockbuster schizophrenia drug Zyprexa.
A landmark patent case before the U.S. Supreme Court this week could have broad implications for research exemptions to patent infringement liability.
A committee of the U.S. House of Representatives has drafted a proposal for a radical overhaul of U.S. patent law, including the establishment of post-grant opposition procedures and the abolition of increased damages based on willful infringement.
A Delaware federal court has postponed the trial in Impax Laboratories, Inc.’s patent challenge against Shire Pharmaceuticals Group’s best-selling attention-deficit-disorder treatment Adderall XR until February 2006.
Three seasoned intellectual property litigators with clients among high-tech companies and financial-services firms have left Morgan & Finnegan to join Chadbourne & Parke LLP’s office in New York as partners, Chadbourne said.